Bill > SB128

This bill introduces several key provisions related to health care in Nevada, focusing on two main areas: prior authorization processes and stem cell therapy information. First, the bill prohibits health insurers, including those for public employees, from using artificial intelligence (AI) systems or automated decision tools as the sole method for denying prior authorization requests, modifying care requests, reducing service coverage, or terminating previously approved care. Insurers must now have a licensed health care professional with appropriate expertise review medical documentation before denying a request. The bill defines key terms like "artificial intelligence system" and "automated decision tool" to provide clarity. Second, the bill encourages physicians, physician assistants, advanced practice registered nurses, and osteopathic physicians to discuss stem cell therapy options with patients diagnosed with conditions like arthritis, and to inform new patients about stem cell donation, banking, and storage possibilities. The legislative findings highlight the potential of stem cell therapy in treating various chronic and potentially debilitating conditions, and aim to increase patient awareness about these medical options. The bill will become fully effective on January 1, 2026, allowing time for regulatory preparation and administrative tasks.

Business and Industry

https://www.leg.state.nv.us/App/NELIS/REL/83rd2025/Bill/12063/Overview